Anti-SARS-CoV-2 T-cell Responses After mRNA Vaccination in Belatacept-treated Renal Transplant Patients.

Dolff, Sebastian; Korth, Johannes; Jahn, Michael; Kribben, Andreas; Witzke, Oliver; Wilde, Benjamin

Dolff, Sebastian; Korth, Johannes; Jahn, Michael; Kribben, Andreas; Witzke, Oliver; Wilde, Benjamin.

Dolff S; Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Korth J; Department of Nephrology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Jahn M; Department of Nephrology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Kribben A; Department of Nephrology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Witzke O; Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Wilde B; Department of Nephrology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Transplantation ; 105(9): e99, 2021 09 01.

Article in English | MEDLINE | ID: covidwho-1219189

Subject(s)

Kidney Transplantation; Vaccines; Abatacept/therapeutic use; Humans; Immunosuppressive Agents/adverse effects; Kidney Transplantation/adverse effects; RNA, Messenger; SARS-CoV-2; T-Lymphocytes/immunology; Transplant Recipients; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / Kidney Transplantation Topics: Vaccines Limits: Humans Language: English Journal: Transplantation Year: 2021 Document Type: Article Affiliation country: Tp.0000000000003812

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google